Pharmafile Logo
Pharmafocus logo
Advanced Search

Approval granted for first oral vasculitis treatment in Japan

September 27, 2021
Sales and Marketing

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) has announced that Japan’s Ministry of Health and Labour Welfare (MHLW) has granted …

News
mat-napo-pij34zrzeew-unsplash

AstraZeneca and Sputnik Light combined vaccines reveal antibody growth

September 27, 2021
Sales and Marketing

A clinical study of the combination of AstraZeneca and Sputnik Light vaccines, conducted in Azerbaijan, has revealed strong neutralising antibodies …

News
nigel-tadyanehondo-god2mdnujuu-unsplash

Driver shortages: UK pharmacies left in dark by government

September 27, 2021
Business Services, Medical Communications, Sales and Marketing

Pharmacists in the UK have been left in the dark by the government, as they still don’t know what measures …

News

COVAX to revamp allocation system as smaller countries miss out on doses

September 27, 2021
Medical Communications, Sales and Marketing

COVAX is set to change its vaccine allocation methodology as it does not take into account a country’s vaccinated population, …

News

Theramex pioneers new treatment for post-menopausal women

September 24, 2021
Medical Communications

Theramex has recently launched the first and only body-identical hormone therapy treatment (HRT) for post-menopausal women, in the form of …

News

Eurazeo set to become leading investor in Kurma Partners

September 24, 2021
Medical Communications

Eurazeo has announced its intention to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology …

News

AstraZeneca and MSD’s Lynparza shows potential for prostate cancer patients

September 24, 2021
Medical Communications

The PROpel Phase III trial has shown that Lynparza (olaparib) in combination with abiraterone demonstrated a significant improvement in radiographic …

News
az

AstraZeneca and VaxEquity to collaborate on saRNA platform

September 24, 2021
Medical Communications

AstraZeneca and VaxEquity have announced a collaboration to progress VaxEquity’s platform technology through proof of concept to enable the development …

News

CGT Catapult and Quell Therapeutics enter manufacturing collaboration

September 24, 2021
Medical Communications

CGT Catapult and Quell Therapeutics have announced a collaboration to facilitate an expanded manufacturing footprint focusing on the manufacturing capacity …

News

Pfizer COVID-19 vaccine to be given to older and at-risk Americans

September 23, 2021
Business Services

The FDA have approved a booster dose of the Pfizer BioNTech COVID-19 vaccine for those aged 65 and above, as …

News

Allarity Therapeutics partners with Lonza to manufacture Dovitinib

September 23, 2021
Business Services

Allarity Therapeutics, a clinical-stage precision medicine company, has announced its collaboration with biopharma partner Lonza to manufacture dovitinib. Dovitinib targets …

News

Italy triples COVID vaccine donation pledge

September 23, 2021

Italy has announced plans to donate 45 million doses of COVID-19 vaccines to other countries by the end of the …

News

Valneva expand COVID vaccine trials amid EC contract bid

September 23, 2021

Valneva has announced the expansion of trials for its COVID-19 vaccine candidate, VLA2001, as it remains in talks with the …

News
white-46040b7c-9161-4bd9-82b0-b36120519a07_1_1

Children in India to receive COVID-19 vaccine from October

September 22, 2021
Research and Development

  All Indian children aged 12 or older will become eligible for their COVID-19 vaccinations from next month, in the …

News
christianschetter

Dr. Christian Schetter hired as Chief Scientific Officer at Rentschler Biopharma

September 22, 2021
Research and Development

Rentschler Biopharma has announced the appointment of Dr. Christian Schetter as their new CSO. In this position, Schetter will be …

Appointment

HCA Healthcare to become one of MPT’s top tenants

September 22, 2021
Research and Development

Medical Properties Trust (MPT) and HCA Healthcare have agreed to a 15-year master lease for hospitals representing $1.2 billion of …

News

CHMP recommends GSK’s Nucala (mepolizumab) for three eosinophil-driven diseases

September 22, 2021
Research and Development

  GlaxoSmithKline (GSK) has announced that the Committee for Medicinal Products for Human Use (CHMP) has issued positive feedback on …

News

Novartis champion advanced breast cancer survival data at ESMO 2021

September 22, 2021
Research and Development

Novartis has presented captivating new data in advanced breast cancer, which championed the longest ever reported median overall survival, as …

News

University of Edinburgh partners with Cancer Research UK to build startup companies

September 22, 2021
Research and Development

The University of Edinburgh’s Venture Builder Incubator, a business support programme, has partnered with Cancer Research UK to help build …

News

Government report finds serious overprescription issues in England

September 22, 2021
Medical Communications, Research and Development

A government report has found serious overprescription issues in England, with 10% of items dispensed in primary care being overprescribed, …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026